Oslo Cancer Cluster`s next member meeting will be an R&D Network Meeting on “Conjugated antibodies”. This will take place October 29th at the Institute for Cancer Research, Oslo University Hospital.
The R&D Network will focus on opportunities and challenges with conjugated antibodies, new treatment options and the clinical perspectives on the use of antibody-drug conjugates. The program also include an update on funding opportunities from the Norwegian Research Council and Innovation Norway.
Program will be sent out shortly. Please save the date and register here.
Please note that only people working in companies and institutions that are members of the Oslo Cancer Cluster may participate at the R&D Network Member Meetings.